KRT20 and neoplasm: In the large cohort of organoid lines established by Mullenders et al. [17] from different historical tumor types, some organoids were found to express both KRT5 and KRT20 in different cell layers or have a more dominant cell type, while TP63 and CD44 were ubiquitously expressed in both normal and tumor-derived organoids [17].